Merck Tbk PT operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Merck Tbk PT with three other
pharmaceutical manufacturers in Asia:
Ttk Healthcare Limited
sales of 5.33 billion Indian Rupees [US$75.54 million]
of which 52%
(1.87 trillion Dong [US$80.62 million]
Samil Pharmaceutical Co., Ltd.
based in South Korea
(92.04 billion Korean Won [US$82.10 million]
Merck Tbk PT reported sales of 1.16 trillion Indonesian Rupiahs (US$82.24 million)
December of 2017.
increase of 11.8%
versus 2016, when the company's sales were 1.03 trillion Indonesian Rupiahs.
This was the third consecutive year of growth at Merck Tbk PT.
Sales of Pharmaceutical saw an increase
13.9% in 2017, from
438.40 billion Indonesian Rupiahs to 499.26 billion Indonesian Rupiahs.